Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research ...

Signs at AMPAC Fine Chemicals' location in the Petersburg Industrial Park have already been changed to 'Novo Nordisk' in advance of the acquisition ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ: MDGL), could bode well for Novo Nordisk A/S (NYSE: NVO). The pharma industry giant has seen explosive sales growth for its ...

Merck has partnered with Hansoh, a Chinese biopharmaceutical company, for a global licensing deal to develop an oral GLP-1 ...

Novo still maintains a 65% market share in global GLP-1 volume. The article "Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon" first appeared on MarketBeat.

Catalent’s common stock has ceased trading and will be delisted from the New York Stock Exchange. Shortly following the completion of the transaction, Novo Nordisk A/S will acquire from Novo ...

Novo still maintains a 65% market share in global GLP-1 volume. The article "Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon" first appeared on MarketBeat. Paid Post: Content produced by ...

Murphy as governor of New Jersey was never going to be dull. But wild-card factors that might have seemed far-fetched a year ago have combined to unleash something rare in the state: a competitive ...

Novo Nordisk, a leading global healthcare company, announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks the ...